tiprankstipranks
Trending News
More News >
Daito Chemix Corporation (JP:4366)
:4366
Japanese Market
Advertisement

Daito Chemix Corporation (4366) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4366

Daito Chemix Corporation

(4366)

Rating:81Outperform
Price Target:
¥908.00
▼(-6.68% Downside)
Daito Chemix Corporation's stock score is driven by strong technical momentum and attractive valuation metrics, indicating potential undervaluation and positive price trends. Financial performance adds to the positive outlook, with improvements in profitability and cash flow, though ROE remains an area for growth.

Daito Chemix Corporation (4366) vs. iShares MSCI Japan ETF (EWJ)

Daito Chemix Corporation Business Overview & Revenue Model

Company DescriptionDaito Chemix Corporation (4366) is a Japanese chemical company specializing in the production and distribution of chemical products. The company serves various industries by providing a wide range of chemical solutions, including fine chemicals, specialty chemicals, and intermediates. Daito Chemix is known for its commitment to quality and innovation, catering to the needs of sectors such as pharmaceuticals, agriculture, and electronics.
How the Company Makes MoneyDaito Chemix Corporation generates revenue primarily through the sale of its chemical products. The company's key revenue streams include the manufacturing and distribution of fine chemicals and specialty chemicals, which are used in various applications across different industries. Daito Chemix also benefits from strategic partnerships and collaborations with other companies, which help to enhance its market reach and product offerings. Additionally, the company's focus on research and development allows it to innovate and create high-value products, contributing to its financial performance.

Daito Chemix Corporation Financial Statement Overview

Summary
Daito Chemix Corporation exhibits a robust financial position with significant improvements in profitability and cash flow generation. The company shows resilience with strong revenue growth and effective cost management, despite some challenges in ROE. The balance sheet reflects a solid equity base and manageable leverage, suggesting a well-positioned company in the chemicals industry.
Income Statement
75
Positive
Daito Chemix Corporation has shown a strong revenue growth trend with a 17.9% increase from 2024 to 2025, recovering from a dip in 2024. The gross profit margin is 11.1%, and the net profit margin is 4.4%, indicating moderate profitability but a significant improvement from the previous year's loss. The EBIT and EBITDA margins are healthy at 4.5% and 12.8% respectively, reflecting improved operational efficiency.
Balance Sheet
70
Positive
The company maintains a moderate debt-to-equity ratio of 0.37, indicating manageable leverage. The equity ratio stands at 61.1%, showing strong equity financing. However, the return on equity is 5.5%, which, although positive, suggests there is room for improvement in generating returns for shareholders.
Cash Flow
80
Positive
Daito Chemix has demonstrated strong cash flow management with a free cash flow growth rate of 209% from 2024 to 2025, reversing a negative trend. The operating cash flow to net income ratio is 3.35, indicating solid cash generation compared to net income, while the free cash flow to net income ratio of 2.27 underscores effective capital expenditure management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue18.64B18.64B15.81B16.38B16.13B14.00B
Gross Profit2.07B2.07B1.90B2.44B2.93B2.50B
EBITDA2.04B2.38B839.00M2.13B2.36B2.05B
Net Income820.00M820.00M-1.00B922.00M1.58B1.09B
Balance Sheet
Total Assets24.33B24.33B24.98B24.70B21.54B18.82B
Cash, Cash Equivalents and Short-Term Investments2.77B2.77B2.25B2.39B3.42B3.25B
Total Debt5.45B5.45B6.35B4.72B3.99B3.28B
Total Liabilities9.47B9.47B10.45B9.52B7.25B6.07B
Stockholders Equity14.86B14.86B14.54B15.17B14.28B12.76B
Cash Flow
Free Cash Flow0.001.86B-1.71B-1.59B-342.00M2.14B
Operating Cash Flow0.002.75B1.05B404.00M1.15B2.53B
Investing Cash Flow0.00-1.19B-2.67B-2.00B-1.52B-376.00M
Financing Cash Flow0.00-1.03B1.48B563.00M543.00M-281.00M

Daito Chemix Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price973.00
Price Trends
50DMA
767.54
Positive
100DMA
703.01
Positive
200DMA
661.59
Positive
Market Momentum
MACD
56.99
Negative
RSI
72.63
Negative
STOCH
72.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4366, the sentiment is Positive. The current price of 973 is above the 20-day moving average (MA) of 846.10, above the 50-day MA of 767.54, and above the 200-day MA of 661.59, indicating a bullish trend. The MACD of 56.99 indicates Negative momentum. The RSI at 72.63 is Negative, neither overbought nor oversold. The STOCH value of 72.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4366.

Daito Chemix Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥10.34B12.05
1.68%13.02%
77
Outperform
¥8.79B13.04
2.92%-3.57%-47.05%
73
Outperform
¥6.11B8.52
3.24%19.66%-13.42%
68
Neutral
¥4.75B33.13
1.22%-5.30%-6.24%
65
Neutral
¥6.69B6.50
1.91%6.80%-19.87%
61
Neutral
$10.31B6.290.71%2.95%3.36%-36.41%
46
Neutral
¥5.03B521.41
2.54%1.73%-914.83%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4366
Daito Chemix Corporation
973.00
369.53
61.23%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
2,874.00
173.34
6.42%
JP:4360
MANAC Chemical Partners Co.,Ltd
583.00
47.45
8.86%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
278.00
1.29
0.47%
JP:4960
Chemipro Kasei Kaisya,Ltd.
287.00
-100.01
-25.84%
JP:6568
KNC Laboratories Co.,Ltd.
1,130.00
-37.68
-3.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 29, 2025